highly significantp < 0.001
Results Patients with a T4 tumor who received postoperative chemotherapy had a highly significant survival benefit in respect of overall survival ( p < 0.001) and recurrence-free survival ( p = 0.008).
Results Patients with a T4 tumor who received postoperative chemotherapy had a highly significant survival benefit in respect of overall survival ( p < 0.001) and recurrence-free survival ( p = 0.008).